Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C

Published:2016-10-26 Issue:2 Volume:83 Page:269-293
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Talavera Pons Sarah¹,Boyer Anne¹,Lamblin Geraldine²,Chennell Philip¹³,Châtenet François-Thibault¹,Nicolas Carine²,Sautou Valérie¹³,Abergel Armand²⁴

Affiliation:

1. Service de Pharmacie Centre Hospitalier Universitaire; Clermont-Ferrand France

2. Service de Médecine Digestive et Hépato-biliaire Centre Hospitalier Universitaire Estaing; Clermont-Ferrand France

3. EA 4676 C-Biosenss; Université d'Auvergne; Clermont-Ferrand Cedex France

4. Unité Mixte de Recherche Université d'Auvergne, CNRS 6284; University of Clermont-Ferrand; France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13095/fullpdf

Reference121 articles.

1. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands;Southan;Nucl Acids Res,2016

2. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015

3. The Concise Guide to PHARMACOLOGY 2015/16: Transporters;Alexander;Br J Pharmacol,2015

4. The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosis;Pearlman;Gastroenterology,2015

5. Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting;Höner;Liver Int,2015

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of comorbid conditions and prescribed chronic medications on the treatment plan for chronic hepatitis C infection: A cross‐sectional retrospective study;Health Science Reports;2024-04-29

2. Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis;Therapeutics and Clinical Risk Management;2023-08

3. Fitness-Dependent, Mild Mutagenic Activity of Sofosbuvir for Hepatitis C Virus;Antimicrobial Agents and Chemotherapy;2023-07-18

4. Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patients;Liver International;2023-03-08

5. TASL, TADE, and DAROC consensus for the screening and management of hepatitis C in patients with diabetes;Journal of the Formosan Medical Association;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3